Not applicableStudy completedNCT05939856What this trial is testingLymph Node Dissection Before or After CystectomyWho this might be right forBladder Cancer Jagiellonian University 50
Large-scale testing (Phase 3)Looking for participantsNCT06929286What this trial is testingA Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-Muscle Invasive Bladder Cancer Memorial Sloan Kettering Cancer Center 125
Not applicableWithdrawnNCT01826097What this trial is testingImproving Sensitivity of Urine Cytology for Bladder CancerWho this might be right forBladder Cancer Johns Hopkins University
Not applicableUnknownNCT06245759What this trial is testingThe Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer PatientsWho this might be right forNon-Muscle-Invasive Bladder CancerBladder Cancer Huazhong University of Science and Technology 120,000
Not applicableWithdrawnNCT00084578What this trial is testingCelecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWho this might be right forBladder Cancer Fox Chase Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05483868What this trial is testingA Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerWho this might be right forNon-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more Aura Biosciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06704191What this trial is testingIn-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE TrialWho this might be right forNon-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more Mayo Clinic 40
Not applicableEnded earlyNCT02145390What this trial is testingChemoradiation for Bladder Preservation After Complete Response to Neoadjuvant ChemotherapyWho this might be right forBladder CancerBladder CarcinomaTransition Cell Cancer+1 more University of Miami 1
Testing effectiveness (Phase 2)Study completedNCT02343614What this trial is testingCelecoxib for the Treatment of Non-muscle Invasive Bladder CancerWho this might be right forNon Muscle Invasive Bladder Cancer Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Not applicableStudy completedNCT01750970What this trial is testingEndoscopic Resection of Bladder TumorsWho this might be right forBladder Tumor Hopital Foch 68
Early research (Phase 1)Not Yet RecruitingNCT07725796What this trial is testingDose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBCWho this might be right forBladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Post-approval studies (Phase 4)Study completedNCT02214602What this trial is testingValue of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder CancerWho this might be right forCarcinoma of Urinary Bladder, Superficial Mansoura University 240
Testing effectiveness (Phase 2)Looking for participantsNCT05951179What this trial is testingSafety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer Protara Therapeutics 131
Not applicableStudy completedNCT02861196What this trial is testingResearch on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder CancerWho this might be right forBladder Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Testing effectiveness (Phase 2)Looking for participantsNCT06394570What this trial is testingEnfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder CancerWho this might be right forBladder Cancer University of Texas Southwestern Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07475403What this trial is testingUrinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder CancerWho this might be right forBladder CancerLiquid BiopsyImmunotherapy Tianjin Medical University Second Hospital 53
Very early researchStudy completedNCT04018053What this trial is testing18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical CystectomyWho this might be right forBladder CancerUrothelial Carcinoma Brigham and Women's Hospital 16
Testing effectiveness (Phase 2)WithdrawnNCT05120622What this trial is testingTrial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder CancerWho this might be right forBladder CancerHigh-Risk CancerTremelimumab+2 more University of British Columbia
Not applicableLooking for participantsNCT07036731What this trial is testingA Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth SequencingWho this might be right forNon Muscle Invasive Bladder Cancer The First Affiliated Hospital with Nanjing Medical University 428
Not applicableStudy completedNCT07402317What this trial is testingTrimodality Bladder PreservationWho this might be right forBladder Cancer Treatment Al-Azhar University 97